Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
0.4699
+0.0052 (1.12%)
At close: Oct 16, 2026, 4:00 PM EDT
0.4520
-0.0179 (-3.81%)
After-hours: Oct 16, 2026, 7:32 PM EDT
Caribou Biosciences Employees
Caribou Biosciences had 97 employees as of December 31, 2025. The number of employees decreased by 50 or -34.01% compared to the previous year. That makes Caribou Biosciences the 31,631st largest employer in the world and 4,067th in the United States.
Employees
97
Change (1Y)
-50
Growth (1Y)
-34.01%
Revenue / Employee
$103,454
Profits / Employee
-$1,066,010
Market Cap
50.38M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 97 | -50 | -34.01% |
| Dec 31, 2024 | 147 | -11 | -6.96% |
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Adicet Bio | 102 |
| Mereo BioPharma Group | 39 |
| Boundless Bio | 28 |
| iBio, Inc. | 23 |
| LeonaBio | 19 |
| MiNK Therapeutics | 15 |
| Werewolf Therapeutics | 14 |
| Alterity Therapeutics | 11 |
CRBU News
- 10 days ago - Caribou Biosciences moved to No Rating at BofA - TheFly
- 10 days ago - Caribou Biosciences downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 11 days ago - Why is Caribou Biosciences Stock (CRBU) Down 43% Today? - TipRanks
- 11 days ago - Caribou Biosciences downgraded to Market Perform from Outperform at Leerink - TheFly
- 11 days ago - Caribou Biosciences downgraded to Sector Perform from Outperform at RBC Capital - TheFly
- 12 days ago - Caribou Biosciences downgraded to Hold from Buy at Brookline - TheFly
- 12 days ago - Caribou Biosciences trading resumes - TheFly
- 12 days ago - Caribou to discontinue development activities, explore alternatives - TheFly